MENU
+Compare
AFMD
Stock ticker: NASDAQ
AS OF
Apr 3, 02:13 PM (EDT)
Price
$0.64
Change
-$0.07 (-9.86%)
Capitalization
11.67M

AFMD Affimed NV Forecast, Technical & Fundamental Analysis

Affimed NV is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
AFMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AFMD with price predictions
Apr 02, 2025

AFMD's Stochastic Oscillator is remaining in oversold zone for 17 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AFMD advanced for three days, in of 235 cases, the price rose further within the following month. The odds of a continued upward trend are .

AFMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AFMD as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AFMD turned negative on March 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AFMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AFMD entered a downward trend on April 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.627) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (11.561) is also within normal values, averaging (252.036).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AFMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AFMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AFMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AFMD is expected to report earnings to fall 6.27% to -56 cents per share on May 21

Affimed NV AFMD Stock Earnings Reports
Q1'25
Est.
$-0.57
Q4'24
Beat
by $0.11
Q3'24
Missed
by $0.09
Q2'24
Missed
by $0.04
Q1'24
Beat
by $0.28
The last earnings report on March 27 showed earnings per share of -60 cents, beating the estimate of -71 cents. With 100.05K shares outstanding, the current market capitalization sits at 11.67M.
A.I. Advisor
published General Information

General Information

a developer of antibody-based therapeutic drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Gottlieb-Daimler-Strabe 2
Phone
+49 621560030
Employees
78
Web
https://www.affimed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLRX3.100.18
+6.16%
BioLineRx Ltd
FVRR24.490.52
+2.17%
Fiverr International Ltd
AVY180.581.02
+0.57%
Avery Dennison Corp
NOMD19.660.01
+0.05%
Nomad Foods Limited
MITT7.19-0.11
-1.51%
AG Mortgage Investment Trust

AFMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AFMD has been loosely correlated with BYSI. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if AFMD jumps, then BYSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AFMD
1D Price
Change %
AFMD100%
+0.30%
BYSI - AFMD
40%
Loosely correlated
-3.09%
GPCR - AFMD
40%
Loosely correlated
+7.35%
NTLA - AFMD
34%
Loosely correlated
+9.69%
SNPX - AFMD
33%
Loosely correlated
-2.56%
LRMR - AFMD
32%
Poorly correlated
+10.00%
More